271 related articles for article (PubMed ID: 35986869)
1. The role and molecular mechanism of gut microbiota in Graves' orbitopathy.
Li Y; Luo B; Tong B; Xie Z; Cao J; Bai X; Peng Y; Wu Y; Wang W; Qi X
J Endocrinol Invest; 2023 Feb; 46(2):305-317. PubMed ID: 35986869
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota in experimental murine model of Graves' orbitopathy established in different environments may modulate clinical presentation of disease.
Masetti G; Moshkelgosha S; Köhling HL; Covelli D; Banga JP; Berchner-Pfannschmidt U; Horstmann M; Diaz-Cano S; Goertz GE; Plummer S; Eckstein A; Ludgate M; Biscarini F; Marchesi JR;
Microbiome; 2018 May; 6(1):97. PubMed ID: 29801507
[TBL] [Abstract][Full Text] [Related]
3. Modulating gut microbiota in a mouse model of Graves' orbitopathy and its impact on induced disease.
Moshkelgosha S; Verhasselt HL; Masetti G; Covelli D; Biscarini F; Horstmann M; Daser A; Westendorf AM; Jesenek C; Philipp S; Diaz-Cano S; Banga JP; Michael D; Plummer S; Marchesi JR; Eckstein A; Ludgate M; Berchner-Pfannschmidt U;
Microbiome; 2021 Feb; 9(1):45. PubMed ID: 33593429
[TBL] [Abstract][Full Text] [Related]
4. The Role of the Microbiota in Graves' Disease and Graves' Orbitopathy.
Hou J; Tang Y; Chen Y; Chen D
Front Cell Infect Microbiol; 2021; 11():739707. PubMed ID: 35004341
[TBL] [Abstract][Full Text] [Related]
5. A Promising Mouse Model of Graves' Orbitopathy Induced by Adenovirus Expressing Thyrotropin Receptor A Subunit.
Zhang M; Ding X; Wu LP; He MQ; Chen ZY; Shi BY; Wang Y
Thyroid; 2021 Apr; 31(4):638-648. PubMed ID: 33076782
[No Abstract] [Full Text] [Related]
6. Comparative assessment of gut microbial composition and function in patients with Graves' disease and Graves' orbitopathy.
Shi TT; Xin Z; Hua L; Wang H; Zhao RX; Yang YL; Xie RR; Liu HY; Yang JK
J Endocrinol Invest; 2021 Feb; 44(2):297-310. PubMed ID: 32449092
[TBL] [Abstract][Full Text] [Related]
7. A cyclic peptide significantly improves thyroid function, thyrotropin-receptor antibodies and orbital mucine /collagen content in a long-term Graves' disease mouse model.
Diana T; Ungerer M; Wüster C; Faßbender J; Li Z; Reimann A; Holthoff HP; Kanitz M; Kahaly GJ
J Autoimmun; 2021 Aug; 122():102666. PubMed ID: 34144327
[TBL] [Abstract][Full Text] [Related]
8. Cre-loxP System-Based Mouse Model for Investigating Graves' Disease and Associated Orbitopathy.
Bao Y; Kim D; Cho YH; Ku CR; Yoon JS; Lee EJ
Thyroid; 2023 Nov; 33(11):1358-1367. PubMed ID: 37624749
[No Abstract] [Full Text] [Related]
9. Mouse model of Graves' orbitopathy induced by the immunization with TSHR A and IGF-1R α subunit gene.
Wu R; Li N; Wang X; Wang S; Tan J; Wang R; Zheng W
J Endocrinol Invest; 2024 Apr; ():. PubMed ID: 38662129
[TBL] [Abstract][Full Text] [Related]
10. Genetic immunization with mouse thyrotrophin hormone receptor plasmid breaks self-tolerance for a murine model of autoimmune thyroid disease and Graves' orbitopathy.
Schlüter A; Horstmann M; Diaz-Cano S; Plöhn S; Stähr K; Mattheis S; Oeverhaus M; Lang S; Flögel U; Berchner-Pfannschmidt U; Eckstein A; Banga JP
Clin Exp Immunol; 2018 Mar; 191(3):255-267. PubMed ID: 29058307
[TBL] [Abstract][Full Text] [Related]
11. The Potential Role of Pyrroloquinoline Quinone to Regulate Thyroid Function and Gut Microbiota Composition of Graves' Disease in Mice.
Liu X; Jiang W; Lu G; Qiao T; Gao D; Zhang M; Cai H; Chai L; Yi W; Lv Z
Pol J Microbiol; 2023 Dec; 72(4):443-460. PubMed ID: 38095308
[TBL] [Abstract][Full Text] [Related]
12. Gut Microbiome Associated With Graves Disease and Graves Orbitopathy: The INDIGO Multicenter European Study.
Biscarini F; Masetti G; Muller I; Verhasselt HL; Covelli D; Colucci G; Zhang L; Draman MS; Okosieme O; Taylor P; Daumerie C; Burlacu MC; Marinò M; Ezra DG; Perros P; Plummer S; Eckstein A; Salvi M; Marchesi JR; Ludgate M
J Clin Endocrinol Metab; 2023 Jul; 108(8):2065-2077. PubMed ID: 36683389
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous induction of Graves' hyperthyroidism and Graves' ophthalmopathy by TSHR genetic immunization in BALB/c mice.
Xia N; Ye X; Hu X; Song S; Xu H; Niu M; Wang H; Wang J
PLoS One; 2017; 12(3):e0174260. PubMed ID: 28319174
[TBL] [Abstract][Full Text] [Related]
14. Intestinal permeability is associated with aggravated inflammation and myofibroblast accumulation in Graves' orbitopathy: the MicroGO study.
Fenneman AC; van der Spek AH; Hartstra A; Havik S; Salonen A; de Vos WM; Soeters MR; Saeed P; Nieuwdorp M; Rampanelli E
Front Endocrinol (Lausanne); 2023; 14():1173481. PubMed ID: 38107520
[TBL] [Abstract][Full Text] [Related]
15. An Early Wave of Macrophage Infiltration Intertwined with Antigen-Specific Proinflammatory T Cells and Browning of Adipose Tissue Characterizes the Onset of Orbital Inflammation in a Mouse Model of Graves' Orbitopathy.
Philipp S; Horstmann M; Hose M; Daser A; Görtz GE; Jesenek C; Flögel U; Hansen W; Bechrakis N; Banga JPS; Eckstein A; Berchner-Pfannschmidt U
Thyroid; 2022 Mar; 32(3):283-293. PubMed ID: 34779257
[No Abstract] [Full Text] [Related]
16. Alterations in the intestinal microbiota of patients with severe and active Graves' orbitopathy: a cross-sectional study.
Shi TT; Xin Z; Hua L; Zhao RX; Yang YL; Wang H; Zhang S; Liu W; Xie RR
J Endocrinol Invest; 2019 Aug; 42(8):967-978. PubMed ID: 30674011
[TBL] [Abstract][Full Text] [Related]
17. Fingolimod Improves the Outcome of Experimental Graves' Disease and Associated Orbitopathy by Modulating the Autoimmune Response to the Thyroid-Stimulating Hormone Receptor.
Plöhn S; Hose M; Schlüter A; Michel L; Diaz-Cano S; Hendgen-Cotta UB; Banga JP; Bechrakis NE; Hansen W; Eckstein A; Berchner-Pfannschmidt U
Thyroid; 2019 Sep; 29(9):1286-1301. PubMed ID: 31237525
[TBL] [Abstract][Full Text] [Related]
18. Peripheral blood mononuclear cells - Can they provide a clue to the pathogenesis of Graves' Orbitopathy?
Basak M; Sanyal T; Kar A; Bhattacharjee P; Das M; Chowdhury S
Endocrine; 2022 Feb; 75(2):447-455. PubMed ID: 34545512
[TBL] [Abstract][Full Text] [Related]
19. Current insights into the pathogenesis of Graves' orbitopathy.
Eckstein AK; Johnson KT; Thanos M; Esser J; Ludgate M
Horm Metab Res; 2009 Jun; 41(6):456-64. PubMed ID: 19530272
[TBL] [Abstract][Full Text] [Related]
20. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
Yin X; Latif R; Bahn R; Tomer Y; Davies TF
Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]